L-asparaginase, also known as amidohydrolase, catalyzes the breakdown of asparagine into aspartic acid and ammonia. Due to its ability to inhibit the biosynthesis of protein lymphoblasts, it is used to treat acute lymphoblastic leukemia (ALL). It also has other applications in the food industry by preventing the formation of acrylamide. Different organisms including bacteria, fungi, actinomycetes, and plants produce L-asparaginase. This review highlights different applications of L-asparaginase in the industrial fields, the major sources of L-asparaginase, its immunological reactions and production techniques through the solid state (SSF) and submerged (SmF) fermentation as well as optimization of the production process.
Introduction
Enzymes play an important role in metabolic and biochemical reactions and microorganisms are the primary source [1] because they can be cultured in large quantities in a short span of time [2, 3] . Proteins that are used as therapeutics have made a great effect in the healthcare area, as they are specific in the disease, highly effective drug, and safe. They have a broad difference of specific utilities as thrombolytics and oncolytic. One of this therapeutic protein is L-asparaginase which has been found to be effective for the treatment of acute lymphoblastic leukemia [4] .
Malignant cells differ from the normal cells, that it can barely synthesize L-asparagine, due to the absence of L-asparagine synthetase, so draining the circulating pools of L-asparagine by L-asparaginase leads to tumor cells destruction, so they could not be able to complete the synthesis of the protein through inhibition of RNA and DNA synthesis with subsequent blastic cell apoptosis [5] .
L-asparaginase has been combined to the multidrug chemotherapy in adults and children with Hodgkin's disease, lymphosarcoma, reticulosarcoma, acute lymphoblastic leukemia, acute myelocytic leukemia, and melanosarcoma and it provides significant improvement of the outcomes of the therapy to achieve complete remission in about 90% of patients [6] .
Recent advances in food technology have explained that pretreatment of potato slices and bread dough with asparaginase before frying or baking prevents acrylamide formation (carcinogenic toxicant) used in a large number of food products that are prepared at temperatures above 100 ºC [7] .
L-asparaginase, application, types, and sources
L-asparaginase (asparagine amidohydrolase) is a tetramer protein, otherwise called aminohydrolase relates to the amidase group of the enzyme and can break down L-asparagine into aspartic acid and ammonia [8].
Its application as a tumor inhibitor
It has a chemotherapeutic characteristic against the tumor cells. It is a powerful curable agent for treatment of lymphosarcoma and acute lymphoblastic leukemia [9] . L-asparaginase is the first curative protein with antineoplastic properties that have been examined comprehensively by many researchers far and wide [8] .
L-asparaginase is recorded in the nineteenth WHO List of Essential Medicines and WHO Model List of Essential Medicines for Children as a cytotoxic and adjunctive treatment for intense lymphoblastic leukemia. Among different treatments, for example, corticosteroid and vincristine, L-asparaginase is utilized as a remission induction chemotherapy standard treatment alternative for recently diagnosed acute lymphoblastic leukemia [10] . It is used also as a central nervous system-directed systemic chemotherapy prophylaxis with dexamethasone and methotrexate for the high and standard-risk acute lymphoblastic leukemia. However, it could not penetrate into the cerebrospinal fluid (CSF), but it could deplete the CSF asparagine.
L-asparaginase discovery and development as an anti-cancer drug started in 1953 when Kidd initially noticed that the lymphomas in mice and rats disappeared after the treatment with the serum of guinea pig. Subsequent investigations demonstrated that it was the enzyme Lasparaginase which was in charge of the tumor relapse [11] . Other authors demonstrated that malignantly changed hematopoietic cells are now and again unfit to form adequate asparagine for their own metabolism when there is no dietary supply of this amino acid. The consumption of the systemic pool of asparagine performed by Lasparaginase will then prompt death to the cells [12] . Altenbern in 1954 and Broome in 1965 reported the antitumor activity of L-asparaginase in bacteria and yeast, respectively [8] . Lasparaginase is present in guinea pigs serum and rodents but is truant in humans. Two isozymes of L-asparaginase, in particular, type I and type II, have been recognized by Ohnuma [13] . Both type I and type II asparaginases are portrayed by enzymatic activity for both L-glutamine and Lasparagine. In any case, type II asparaginase shows higher particular action towards Lasparagine. Type II asparaginase definitely demonstrates antitumor activity and is used as chemotherapeutics in ALL [8] .
The molecular basis for L-asparaginase therapeutic use stays badly clarified. In mammalian cells, the amino acid response (AAR) pathway is intended to recognize and react to amino acid inadequacy, which upon ending the supply of L-asparagine, enhances the expression of asparagine synthetase mRNA in the resistant cells. In any case, the expression of asparagine synthetase in susceptible tumor cells is not upregulated may be due to a decrease of the translation initiation, that is realized by the phosphorylation of eukaryotic initiation factors (e.g. eIF-2 a and eIF4e) by a starvation-activated ribosome-associated kinase [14] . L-asparaginase treatment causes specific starvation of the susceptible tumor cells. This L-asparagine starvation prompts the prevention of development of rRNA transcription, trailed by the discouragement of the synthesis of asparaginyl tRNA which limits peptide synthesis. Lasparagine consumption is additionally caused by nucleotide biosynthesis slowing and elongation of the S-phase of the cell cycle. L-asparaginase therapy captures the cell cycle of the tumor cell at the G1 phase before DNA degradation. Ammonium ions (one of the by-products of Lasparaginase activity) change the pH by disruption into the cytosol, which stimulates the pathway of the signal transduction associated with substrate phosphorylation and apoptosis 
L-asparaginase application in food industry
The University of Stockholm and the Swedish Food Authority affirmed the presence of the cancer-causing agent acrylamide in assortments of heated foods ten years ago. A while after the declaration, researchers demonstrated that acrylamide is synthesized from asparagine and reducing sugars during the Maillard reaction (Fig.  3) [17]. Since 2002, the food industry has teamed up with scientists worldwide, in order to lessen the amount of acrylamide in cooked foods. Techniques of mitigation can be isolated into three distinct types. Firstly, using starting materials with a low amount of acrylamide precursors can be utilized to decrease the acrylamide in the last product. Secondly, process parameters may be adjusted, in order to lessen the formation of acrylamide. Thirdly, post-process treatment could be utilized to decrease acrylamide [18]. However, the third approach is not used widely; an example is the utilization of supercritical CO 2 extraction to decrease the levels of acrylamide in coffee. Almost 80% of the acrylamide was expelled utilizing this strategy [19]. Adding other chemicals before or after heating could reduce the amount of the produced acrylamide in a heated product, numerous added substances were utilized, as glycine who can contend with the asparagine to reduce the final acrylamide production, antioxidants and divalent cations as calcium hydroxide all have their side effects (affecting flavor of food) which prevent to be used commercially [20]. Fermentation techniques use certain microorganisms to devour the asparagine or reducing sugar prior to the step of food processing [21]. For example, a basal medium including lactic acid bacteria was utilized in the formation of wholemeal rye bread and considerably diminished levels of acrylamide in the final product [22]. In addition, of decreasing the pH, the lactic acid bacteria lowered the amount of reducing sugars in the dough.
In the fermentation approach, there are many points which need to be taken into consideration. Starting with, the temperature and pH should be controlled in order to increase the activity of the microorganism to the maximum. Regardless of the reducing sugar consumed was included back after processing, the final product's quality may still be influenced by the fermentation step 
Types of L-asparaginase
Bacterial L-asparaginase has been categorized into two large groups named type I and type II based on the homology in the sequence, function, and structure, in addition to various asparaginases that are derived from plant origins [31]. Bacterial L-asparaginases belong to a group of amidohydrolases in which threonine is the essential nucleophile during catalysis. Type I Lasparaginases are cytoplasmic and type II are periplasmic, the latter have high affinity to Lasparagine (Km ¼ 10 -5 M), and to a lesser degree helps in the conversion of L-glutamine into glutamic acid. E.coli L-asparaginase type I and II have similar conserved amino acid motifs, but vary in their quaternary structure, and type I is with a much lower affinity towards L-asparagine (Km ¼ 10 
Plant source
L-asparaginase is a good tumor inhibitor, so a number of new sources must be discovered in order to meet the need of the medical industry. Researchers have mentioned that green chilies (Capsicum annum) and tamarind (Tamarindus indica) can produce an amount of L-asparaginase. An enzyme produced from the green chilies was highly purified up to 400-folds by various techniques and it was detected that enzyme appear in two forms, one of them are found to have a tumor inhibiting effect [9].
L-asparaginase structure
Many researchers to find out L-asparaginase molecular structure have performed many studies. After isolation of L-asparaginase from various sources, it was mentioned that Lasparaginase usually presents as a tetramer and may appear as monomeric, dimeric and hexameric forms. L-asparaginases from bacterial source mostly possess quaternary and tertiary structures [75] . E. coli and Erwinia sp. Lasparaginases are studied in a good way so their structures at the molecular levels and their information is easily abundant [76, 77] . Both E. coli and Erwinia sp. are identical in the threedimensional structures [78] . Erwinia carotovora L-asparaginase existed as two tetramers formed from four similar monomers each. I each monomer, three hundred twenty-seven amino acids gather with 14 α-strands, eight β-helices [79], and two domains, a big N-terminal domain and a small C-terminal domain [76] . In between the two adjoining monomers, the active site is located. The tetramer formed from four identical subunits. The entire molecule is observed as a dimer of dimers [80, 81].
Immunological reaction
By increasing the molecular weight of the protein, higher structure complexity and proteins made of many similar subunits with a molecular weight of > 100 KDa the immunogenicity of the protein becomes higher. Clinical trials have demonstrated that the application of the asparaginase molecule, which comprises four similar subunits and has about 140 KDa molecular weight leads to the production of certain antibodies in numerous patients. The antibody reactions range from systemic anaphylaxis to localized erythema and pain at the site of injection and may be followed by a high rate of inactivation to the enzyme. In some reports, the asparaginase is inactivated rapidly in patients who don't show hypersensitivity clinical signs which are called 'silent inactivation' [82] . Killander et al. tested L-asparaginase from E. coli in two sets including 57 children and 57 adults and revealed that in the adults there were the more frequent appearance of hypersensitivity reactions and a reduction in asparaginase activity in addition to specific antibodies than in the children [83] . As asparaginases from various bacterial strains are accessible which demonstrate only restricted cross-reactivity, regimen continuation in case of immunological reactions to one preparation of asparaginase may be conceivable by choosing an enzyme from a various biological source [12] . As overall, proteins are immunogenic when the molecular weight higher than 6 kDa [7].
Industrial production of L-asparaginase and process optimization
Many parameters need to be taken into consideration for the industrial production of Lasparaginase, intending to a higher production and cost-effective process. The pH, temperature, type, and concentration of carbon and nitrogen sources, aeration, fermentation time, and, particularly, the biological agent, have an extraordinary impact on the process [84] . As mentioned before, many microorganisms are displayed as L-asparaginase producers; however, bacteria E. coli and Erwinia chrysanthemi are the present main microbial sources for industrial production in the pharmaceutical region, while the fungus Aspergillus oryzae is the most commonly used in the food industry [60, 85]. Fig.  4 shows a schematic diagram of the industrial procedures for L-asparaginase production. Glucose at 1% totally represses the enzyme activity while at 0.1 %, it presented marginally stimulatory impact on enzyme production [4] . The production of L-asparaginase was observed by utilizing inorganic nitrogen sources such as ammonium sulfate, ammonium chloride, and ammonium nitrate as well as organic sources such as peptone, yeast extract, and beef extract. The optimum productivity has been reported by using 0.5% yeast extract and 0.5% ammonium sulfate. Consequently, yeast extract and ammonium sulfate have been considered as the best nitrogen sources [92] . As aeration and agitation were the influencing parameters for the enzyme production, low aeration and agitation gave the higher yield production while complete aerobic and anaerobic conditions lowered the yield.
Various techniques stated for production and optimization of L-asparaginase from different microorganisms incorporate solid-state fermentation (SSF) and submerged fermentation (SmF) [93] . Conditions of the process differ from organism to another for enzyme production, and it can be formed constitutively or after induction [94] . Production of L-asparaginase using submerged fermentation was performed by Moorthy et al. [95] . The culture conditions were optimized for the higher production of the enzyme. Two carbon sources, glucose and maltose, were utilized for the enzyme production. Glucose provided better outcomes. The enzyme was activated by MgCl 2 and inhibited by EDTA. Nutritional demands for L-asparaginase production from Fusarium species was examined by Tippani and Sivadevuni [89], using submerged fermentation. Glucose was found to be the best carbon source with Fusarium semitectum (328 IU/mL), Fusarium moniliforme (300 IU/mL) and Fusarium oxysporum (210 IU/mL), while lactose was the second best carbon source for Fusarium oxysporum (178 IU/mL) and Fusarium semitectum (218 IU/mL) and for Fusarium moniliforme mannose was the best one (213 IU/mL) [4] . Nevertheless, solid state fermentation has some advantages including high yield, costeffective, low energy input, simple fermentation media, and low water utilization [96, 97].
Solid-state fermentation has been developed as an effective technology for the production of microorganisms' products using raw materials of low cost. An approach was performed by Hosamani et 
Conclusion
This review article highlights miscellaneous applications of L-asparaginase on the commercial level including medical or food industries as well as improvements of its production processes. Several reports have emphasized on the promising role of L-asparaginase in cancer therapy. Furthermore, L-asparaginase has been introduced in the food industry for the elimination of the carcinogenic compound (acrylamide). In spite of its availability from different sources, microbial L-asparaginase has attracted the attention of the scientists due to its cost-effectiveness and ease of the production. Owing to its commercial value, different approaches have been implemented to optimize L-asparaginase production for higher microbial yields on the industrial level. 
